investors.iobiotech.comIO Biotech, Inc. - Invest in combination cancer therapy
investors.iobiotech.com Profile
Investors.iobiotech.com is a subdomain of iobiotech.com, which was created on 2015-01-05,making it 9 years ago.
Description：We share the latest overview updates for IO Biotech’s combination therapy cancer...
Keywords：T-win, Cancer vaccine, Combination therapy, IOBT, Clinical-stage biopharmaceutical,...
Discover investors.iobiotech.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
investors.iobiotech.com Information
| HomePage size: 69.571 KB |
| Page Load Time: 0.257241 Seconds |
| Website IP Address: 162.159.129.11 |
investors.iobiotech.com Similar Website
| Cancer Epigenetics | A journal of the Cancer Epigenetics Society | Cancer Epigenetics |
| BTF Cancer Center - Transforming Cancer Treatment in Nepal |
| Pediatric Cancer Research Foundation | PCRF | Childhood Cancer Charity |
| Insight – Cancer Information You Can Trust | Dana-Farber Cancer Institute |
| Stop Fighting Food 2021 Combination Page – Stop Fighting Food |
| CarseatBlog – Reviews of the safest infant, rear-facing, convertible and combination carseats for yo |
| MD Anderson Cancer Center: Cancer Treatment & Cancer Research Hospital | MD Anderson Cancer Center |
| The Lotus Tree | Occupational Therapy, Physical Therapy, Speech Therapy, Music Therapy, Manual Thera |
| The Main (Main) audience combination contains no home page. |
| Unique Combination of Insurance Services and Software Development |
| GC biotech webshop – GC biotech – Translating Life Sciences Into |
investors.iobiotech.com PopUrls
| IO Biotech, Inc. - Invest in combination cancer therapy https://investors.iobiotech.com/overview/default.aspx |
| Financials - SEC Filings https://investors.iobiotech.com/financials/sec-filings/default.aspx |
| IO Biotech, Inc. - Resources - Investor FAQs https://investors.iobiotech.com/resources/investor-faqs/default.aspx |
| Stock Info - IO Biotech, Inc. https://investors.iobiotech.com/stock-info/quote/default.aspx |
| Governance - Executive Management https://investors.iobiotech.com/governance/executive-management/default.aspx |
| IO Biotech, Inc. - News & Events https://investors.iobiotech.com/news-events/news/default.aspx |
| Governance Documents https://investors.iobiotech.com/governance/governance-documents/default.aspx |
| Governance - Board of Directors https://investors.iobiotech.com/governance/board-of-directors/default.aspx |
| IO Biotech, Inc. - Resources - Investor Email Alerts https://investors.iobiotech.com/resources/investor-email-alerts/default.aspx |
| Stock Info - Analyst Coverage https://investors.iobiotech.com/stock-info/analyst-coverage/default.aspx |
investors.iobiotech.com Httpheader
| Date: Mon, 13 May 2024 01:42:09 GMT |
| Content-Type: text/html; charset=utf-8 |
| Transfer-Encoding: chunked |
| Connection: keep-alive |
| CF-Ray: 882ef3462e19fab6-SJC |
| CF-Cache-Status: REVALIDATED |
| Cache-Control: public, max-age=10, stale-if-error=86400, stale-while-revalidate=86400 |
| Strict-Transport-Security: max-age=31536000; includeSubDomains |
| Vary: Accept-Encoding |
| X-Content-Type-Options: nosniff |
| X-Frame-Options: SAMEORIGIN |
| X-XSS-Protection: 1; mode=block |
| Server: cloudflare |
investors.iobiotech.com Meta Info
| content="text/html; charset=utf-8" http-equiv="Content-type"/ |
| content="RevealTrans(Duration=0,Transition=0)" http-equiv="Page-Enter"/ |
| content="IE=edge,chrome=1" http-equiv="X-UA-Compatible"/ |
| content="width=device-width, initial-scale=1.0" name="viewport"/ |
| content="default-src 'self' https: http: 'unsafe-inline' 'unsafe-eval' *.q4inc.com; script-src 'self' *.bootstrapcdn.com *.datatables.net *.cloudfront.net *.pusherapp.com *.newrelic.com *.nr-data.net *.bugherd.com *.q4cdn.com *.q4web.com *.amazonaws.com *.highcharts.com *.googletagmanager.com *.googleadservices.com *.google-analytics.com *.google.com *.gstatic.com *.q4app.com *.pendo.io 'unsafe-inline' 'unsafe-eval' *.q4inc.com" http-equiv="Content-Security-Policy"/ |
| content="2IhF5snBXXVwV4eAEI3vsACIraSJ1kLOBA5vTbiVVEk" name="google-site-verification"/ |
| content="We share the latest overview updates for IO Biotech’s combination therapy cancer vaccine." name="description"/ |
| content="T-win, Cancer vaccine, Combination therapy, IOBT, Clinical-stage biopharmaceutical, Immune-modulating, TME, Corporate overview, IO biotech IR" name="keywords"/ |
investors.iobiotech.com Html To Plain Text
Overview Home IR Overview News & Events News Events & Presentations Stock Info Stock Info Analyst Coverage Financials SEC Filings Governance Governance Documents Executive Management Board of Directors Committee Composition Resources Investor FAQs Information Request Form Investor Email Alerts Our Goal: Establish our T-win® immune-modulating cancer vaccine as the backbone of combination therapy for people with cancer. Overview Home IR Overview News & Events News Events & Presentations Stock Info Stock Info Analyst Coverage Financials SEC Filings Governance Governance Documents Executive Management Board of Directors Committee Composition Resources Investor FAQs Information Request Form Investor Email Alerts Corporate Overview IO Biotech is a clinical-stage biopharmaceutical company pioneering the first dual-action immune-modulating cancer vaccine with the goal of becoming the backbone of combination therapy for people with cancer. The Company’s T-win® vaccine platform is directed against the tumor microenvironment (TME) and is designed to stimulate T cells against tumor cells and the most important immune-suppressive cells in the TME. IO Biotech’s most advanced program for IO102-IO103 is currently in Phase 3 development. IO Biotech is headquartered in Copenhagen, Denmark. Latest News View All News Latest Events View All Events Latest Presentation Mission: Establish our T-win® immune-modulating cancer vaccine as the backbone of combination therapy for people with cancer.Mission: Establish our T-win® immune-modulating cancer vaccine as the backbone of combination therapy for people with cancer. Company Team News Careers Presentations Science Overview Programs T-win Pipeline Patients Legal Investors Privacy Policy Cookie Policy Terms of Use Contact [email protected] © IO Biotech, Inc. - All rights reserved. Powered By Q4 Inc. 5.122.0.3 (opens in new...
investors.iobiotech.com Whois
Domain Name: IOBIOTECH.COM Registry Domain ID: 1894161261_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.one.com Registrar URL: http://www.one.com Updated Date: 2023-12-06T01:01:39Z Creation Date: 2015-01-05T10:17:27Z Registry Expiry Date: 2025-01-05T10:17:27Z Registrar: One.com A/S Registrar IANA ID: 1462 Registrar Abuse Contact Email: abuse@one.com Registrar Abuse Contact Phone: +45 44451220 Domain Status: ok https://icann.org/epp#ok Name Server: NS01.ONE.COM Name Server: NS02.ONE.COM DNSSEC: signedDelegation DNSSEC DS Data: 32717 13 2 830603D03913DD186DE2657F710AE9464D9E558BB6862A9C400DFDF2C8960E0C >>> Last update of whois database: 2024-05-17T15:16:16Z <<<